SIC 2833 – Medicinal Chemicals and Botanical Products
Valuation | |
---|---|
Market Cap ($M) | 692.38 |
Enterprise Value ($M) | -119.51 |
Book Value ($M) | 1,110.98 |
Book Value / Share | 2.90 |
Price / Book | 0.62 |
NCAV ($M) | 880.78 |
NCAV / Share | 2.30 |
Price / NCAV | 0.79 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.04 |
Return on Assets (ROA) | 0.04 |
Return on Equity (ROE) | 0.04 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 18.17 |
Current Ratio | 18.84 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 936.11 |
Assets | 1,166.31 |
Liabilities | 55.33 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 117.61 |
Operating Income | -54.27 |
Net Income | 41.08 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 18.84 |
Cash from Investing | 175.15 |
Cash from Financing | -1.23 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Altria Group, Inc. | 41.00 | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
218,790 | 760,567 | 28.77 | |
367,394 | 1,526,632 | 24.07 | |
267,546 | 907,405 | 29.48 | |
701,496 | 1,609,374 | 43.59 | |
(click for more detail) |
Similar Companies | |
---|---|
CLYM – Climb Bio, Inc. | CMRX – Chimerix, Inc. |
CRMD – CorMedix Inc. | CRSP – CRISPR Therapeutics AG |
CRVS – Corvus Pharmaceuticals, Inc. |